Stockreport

Industry Analysts Just Made A Captivating Upgrade To Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF The analysts have sharply increased their revenue numbers, with a view that Arcutis Biotherapeutics will make substantially more sales than they'd previously expected. [Read more]